Morgan Stanley Maintains Equal-Weight on United States Steel, Lowers Price Target to $20
Morgan Stanley analyst Carlos De Alba maintains United States Steel (NYSE:X) with a Equal-Weight and lowers the price target from $27 to $20.
Roth Capital Downgrades Evolution Petroleum to Neutral
Roth Capital analyst John White downgrades Evolution Petroleum (AMEX:EPM) from Buy to Neutral.
ThermoGenesis Reported in Filing Tuesday It Received a Conversion Notice From Boyalife Asset Holding II to Convert a Total of $3M of the Outstanding Balance of the Second Amended and Restated Convertible Promissory Note Issued to Boyalife on April 16,…
On June 28, 2022, ThermoGenesis Holdings, Inc. (the "Company") received a conversion notice from Boyalife Asset Holding II, Inc.("Boyalife") to convert a total of $3,000,000 of the outstanding balance of the Second Amended and Restated Convertible Promissory Note issued by the Company to Boyalife on April 16, 2018, as amended by Amendment No 1 thereto dated March 4, 2022 (as amended, the "Note").
Morgan Stanley Maintains Equal-Weight on Steel Dynamics, Lowers Price Target to $78
Morgan Stanley analyst Carlos De Alba maintains Steel Dynamics (NASDAQ:STLD) with a Equal-Weight and lowers the price target from $94 to $78.
Morgan Stanley Maintains Overweight on State Street, Lowers Price Target to $86
Morgan Stanley analyst Betsy Graseck maintains State Street (NYSE:STT) with a Overweight and lowers the price target from $106 to $86.
Oppenheimer Maintains Outperform on Focus Finl Partners, Lowers Price Target to $52
Oppenheimer analyst Owen Lau maintains Focus Finl Partners (NASDAQ:FOCS) with a Outperform and lowers the price target from $60 to $52.
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours:
Canaccord Genuity Maintains Buy on VSE, Lowers Price Target to $50
Canaccord Genuity analyst Austin Moeller maintains VSE (NASDAQ:VSEC) with a Buy and lowers the price target from $64 to $50.
Morgan Stanley Maintains Equal-Weight on Reinsurance Group, Lowers Price Target to $131
Morgan Stanley analyst Nigel Dally maintains Reinsurance Group (NYSE:RGA) with a Equal-Weight and lowers the price target from $132 to $131.
Morgan Stanley Maintains Equal-Weight on Prudential Financial, Lowers Price Target to $103
Morgan Stanley analyst Nigel Dally maintains Prudential Financial (NYSE:PRU) with a Equal-Weight and lowers the price target from $120 to $103.